Inflammatory Bowel Diseases Clinical Trial
— ACHILLEOfficial title:
Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease
Verified date | May 2023 |
Source | University of Liege |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective interventional study. The investigators will include patients in clinical remission who are on stable treatment. These IBD patients will be followed to analyze the effects of physical activity on their inflammatory disease. Different exercises will be offered to two separate groups of randomly distributed patients: the first group will perform muscle building exercises while the other group will be offered aerobic exercises.There will also be a control group that does not initially benefit from a specific physical activity program. However, this group will be integrated into one of the other two groups after the 10-week follow-up. All three groups will perform the same baseline tests. These will be of different types: physical tests, biological tests and quality of life questionnaires.
Status | Completed |
Enrollment | 24 |
Est. completion date | February 7, 2023 |
Est. primary completion date | December 15, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 50 Years |
Eligibility | Inclusion Criteria: - Patients in remission defined by a Harvey Bradshaw Index 5 in Crohn's disease (CD) and a clinical Mayo 3 with no sub-score >1 in ulcerative colitis (RCUH) with stable treatment, without corticosteroid for 4 months. - Patients accepting the study protocol Exclusion Criteria: - Patients suffering from other pathologies (at the level of the digestive system, the cardiovascular system, as well as the musculoskeletal system: recent knee plasty, recent knee fractures, etc.), which can interfere with planned tests and activity programs. - Patients with more than 3 hours of sports activity per week - Pregnant, pregnant or nursing patients |
Country | Name | City | State |
---|---|---|---|
Belgium | Université de Liège | Liège |
Lead Sponsor | Collaborator |
---|---|
University of Liege |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Progressive effort test on bicycle ergometer (VO2 max) | This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases) | day 1 | |
Primary | Progressive effort test on bicycle ergometer (VO2 max) | This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases) | through study completion, an average of 40 weeks | |
Primary | Progressive effort test on bicycle ergometer (Heart rate) | This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt. | day 1 | |
Primary | Progressive effort test on bicycle ergometer (Heart rate) | This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt. | through study completion, an average of 40 weeks | |
Primary | Progressive effort test on bicycle ergometer (Power) | This test allows to measure maximum aerobic power in Watt. | day 1 | |
Primary | Progressive effort test on bicycle ergometer (Power) | This test allows to measure maximum aerobic power in Watt. | through study completion, an average of 40 weeks | |
Primary | Maximum force test (N/m) | This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m. | Day 1 | |
Primary | Maximum force test (N/m) | This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m. | through study completion, an average of 40 weeks | |
Primary | Blood sample | This type of tests includes biological monitoring to obtain information on biological parameters. | Day 1 | |
Primary | Blood sample | This type of tests includes biological monitoring to obtain information on biological parameters. | through study completion, an average of 40 weeks | |
Primary | Saddle analysis | This type of tests includes biological monitoring to obtain information on biological parameters. | Day 1 | |
Primary | Saddle analysis | This type of tests includes biological monitoring to obtain information on biological parameters. | through study completion, an average of 40 weeks | |
Primary | IBD-F | Participants will complete a questionnaire on fatigue perceived. | Week 1 | |
Primary | IBD-F | Participants will complete a questionnaire on fatigue perceived. | Week 10 | |
Primary | IBD-F | Participants will complete a questionnaire on fatigue perceived. | Week 20 | |
Primary | Godin Leisure Time exercise questionnaire | Participants will complete a questionnaire on the level of physical activity | Week 1 | |
Primary | Metabolic Equivalent Task questionnaire | Participants will complete a questionnaire on the level of inactivity | Week 1 | |
Primary | Metabolic Equivalent Task questionnaire | Participants will complete a questionnaire on the level of inactivity | Week 10 | |
Primary | Metabolic Equivalent Task questionnaire | Participants will complete a questionnaire on the level of inactivity | Week 20 | |
Primary | Short Food Frequency Questionnaire | Participants will complete a questionnaire on their dietary habits | Week 1 | |
Primary | Short Food Frequency Questionnaire | Participants will complete a questionnaire on their dietary habits | Week 10 | |
Primary | Short Food Frequency Questionnaire | Participants will complete a questionnaire on their dietary habits | Week 20 | |
Primary | EQ5D questionnaire | Participants will complete a questionnaire on their level of health | Week 1 | |
Primary | EQ5D questionnaire | Participants will complete a questionnaire on their level of health | Week 10 | |
Primary | EQ5D questionnaire | Participants will complete a questionnaire on their level of health | Week 20 | |
Primary | Short health scale questionnaire | Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease | Week 1 | |
Primary | Short health scale questionnaire | Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease | Week 10 | |
Primary | Short health scale questionnaire | Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease | Week 20 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
Active, not recruiting |
NCT04989907 -
A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
|
||
Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
Active, not recruiting |
NCT04990258 -
A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
|
||
Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
Enrolling by invitation |
NCT06015789 -
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
|
||
Recruiting |
NCT06065995 -
StoMakker Mobile Application
|
N/A | |
Recruiting |
NCT03282786 -
Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease
|
N/A | |
Recruiting |
NCT06002074 -
SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases
|
N/A | |
Recruiting |
NCT04960826 -
Study of an Environmental Risk Factor in Crohn's Disease
|
||
Recruiting |
NCT05413941 -
Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease
|
N/A | |
Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
Completed |
NCT00721812 -
A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686
|
Phase 1 | |
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT04138225 -
The Ecological Role of Yeasts in the Human Gut
|
||
Recruiting |
NCT04991324 -
Cholecalciferol Comedication in IBD - the 5C-study
|
Phase 3 | |
Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
Not yet recruiting |
NCT05043818 -
A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
|
||
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Completed |
NCT02874365 -
Intestinal Stem Cells Characterization
|
N/A |